CTC
IDXX icon

Central Trust Company’s Idexx Laboratories IDXX Stock Holding History

Central Trust Company’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$53.4K Sell
95
-10
-10% -$6.41K ﹤0.01% 835
2025
Q4 		$71.3K Sell
105
-40
-28% -$27.2K ﹤0.01% 752
2025
Q3 		$92.6K Sell
145
-28
-16% -$17K ﹤0.01% 706
2025
Q2 		$92.8K Sell
173
-6
-3% -$2.87K ﹤0.01% 683
2025
Q1 		$75.2K Sell
179
-72
-29% -$31.3K ﹤0.01% 710
2024
Q4 		$104K Sell
251
-67
-21% -$29.4K ﹤0.01% 649
2024
Q3 		$161K Buy
318
+2
+0.6% +$972 ﹤0.01% 580
2024
Q2 		$154K Sell
316
-59
-16% -$29.6K ﹤0.01% 591
2024
Q1 		$202K Sell
375
-45
-11% -$24.6K 0.01% 561
2023
Q4 		$233K Sell
420
-50
-11% -$23.5K 0.01% 526
2023
Q3 		$206K Buy
470
+5
+1% +$2.49K 0.01% 541
2023
Q2 		$234K Hold
465
– – 0.01% 534
2023
Q1 		$233K Sell
465
-7
-1% -$3.35K 0.01% 515
2022
Q4 		$193K Hold
472
– – 0.01% 530
2022
Q3 		$154K Sell
472
-389
-45% -$143K 0.01% 572
2022
Q2 		$302K Sell
861
-492
-36% -$201K 0.01% 458
2022
Q1 		$740K Sell
1,353
-140
-9% -$73.6K 0.02% 353
2021
Q4 		$983K Sell
1,493
-94
-6% -$59K 0.03% 331
2021
Q3 		$987K Sell
1,587
-55
-3% -$37K 0.04% 316
2021
Q2 		$1.04M Buy
1,642
+10
+0.6% +$5.52K 0.04% 303
2021
Q1 		$799K Buy
1,632
+1,232
+308% +$617K 0.03% 328
2020
Q4 		$200K Hold
400
– – 0.01% 480
2020
Q3 		$157K Hold
400
– – 0.01% 482
2020
Q2 		$132K Hold
400
– – 0.01% 492
2020
Q1 		$97K Buy
+400
New +$104K 0.01% 510
2017
Q3 		– Sell
-49
Closed -$8K – 1294
2017
Q2 		$8K Buy
+49
New +$7.96K ﹤0.01% 973
2014
Q1 		– Sell
-440
Closed -$23K – 1201
2013
Q4 		$23K Hold
440
– – ﹤0.01% 815
2013
Q3 		$22K Hold
440
– – ﹤0.01% 814
2013
Q2 		$20K Buy
+440
New +$19.2K ﹤0.01% 790

Other funds holding IDXX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Central Trust Company's IDXX Position: Q1 2026 in Review

Central Trust Company reduced its Idexx Laboratories (IDXX) stake by 9.5% in Q1 2026, selling an estimated $6.41K and leaving 95 shares worth $53.4K. The position accounts for ﹤0.01% of the portfolio, ranked #835.

Central Trust Company first reported a position in IDXX in Q2 2013 and has held it in 29 quarters since. The position peaked at $1.04M in Q2 2021. 1,311 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

  • Central Trust Company held 95 shares of Idexx Laboratories worth $53.4K as of Q1 2026.
  • Central Trust Company sold 10 Idexx Laboratories shares in Q1 2026, an estimated $6.41K.
  • Idexx Laboratories made up ﹤0.01% of Central Trust Company's portfolio in Q1 2026, its #835 holding.
  • Central Trust Company first reported a position in Idexx Laboratories in Q2 2013 and has held it in 29 quarters since.
  • Central Trust Company's Idexx Laboratories position peaked at $1.04M in Q2 2021.
  • 1,311 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Central Trust Company's 13F filing for Q1 2026, filed 17 Apr 2026.